(Q48357495)

English

Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice

scientific article published on 23 February 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

parkinsonian syndrome

1 reference

based on heuristic

inferred from title

author name string

Amit Naskar

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Visakh Prabhakar

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Raghavendra Singh

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Debashis Dutta

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Kochupurackal P Mohanakumar

5

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

publication date

23 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Journal of Pineal Research

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

58

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

262-274

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Experimental models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a neurochemical and morphological reassessment

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatum

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Photobiomodulation enhances nigral dopaminergic cell survival in a chronic MPTP mouse model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Placebo-controlled chronic high-frequency stimulation of the subthalamic nucleus preserves dopaminergic nigral neurons in a rat model of progressive Parkinsonism

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Engraftment of mouse embryonic stem cells differentiated by default leads to neuroprotection, behaviour revival and astrogliosis in parkinsonian rats

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Intrastriatal infusion of the Parkinsonian neurotoxin, MPP(+), induces damage of striatal cell nuclei in Sprague-Dawley rats

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Apoptotic mode of cell death in substantia nigra following intranigral infusion of the parkinsonian neurotoxin, MPP+ in Sprague-Dawley rats: cellular, molecular and ultrastructural evidences

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin: the chemical expression of darkness

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin relieves the neural oxidative burden that contributes to dementias

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin protects against behavioural dysfunctions and dendritic spine damage in 3-nitropropionic acid-induced rat model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin synergizes with low doses of L-DOPA to improve dendritic spine density in the mouse striatum in experimental Parkinsonism.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Exogenous melatonin supplementation prevents oxidative stress-evoked DNA damage in human spermatozoa.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin as a natural ally against oxidative stress: a physicochemical examination.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin: a well-documented antioxidant with conditional pro-oxidant actions

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodents

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin protects nigral dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP+) neurotoxicity in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Protective effect of melatonin in a chronic experimental model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Similarities between Neurologic Effects of L-Dopa and of Apomorphine

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Treatment options for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

The occurrence of motor fluctuations in parkinsonian patients treated long term with levodopa: role of early treatment and disease progression

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Synergistic effects of melatonin and deprenyl against MPTP-induced mitochondrial damage and DA depletion

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

The effect of deprenyl and levodopa on the progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Acute stress or neuroleptics elicit sensorimotor deficits in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Acute intranigral infusion of rotenone in rats causes progressive biochemical lesions in the striatum similar to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

A simple and fast densitometric method for the analysis of tyrosine hydroxylase immunoreactivity in the substantia nigra pars compacta and in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Quantification of renal pathology by image analysis

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin induces tyrosine hydroxylase mRNA expression in the ventral mesencephalon but not in the hypothalamus

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Does levodopa accelerate Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervation

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patients

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Levodopa-induced dyskinesia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Advances in understanding L-DOPA-induced dyskinesia

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Endogenous melatonin protects L-DOPA from autoxidation in the striatal extracellular compartment of the freely moving rat: potential implication for long-term L-DOPA therapy in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Effect of exogenous melatonin on sleep and motor dysfunction in Parkinson's disease. A randomized, double blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin increases striatal dopaminergic function in 6-OHDA-lesioned rats

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Increased melatonin may play dual roles in the striata of a 6-hydroxydopamine model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

MPTP-induced hypoactivity in mice: reversal by L-dopa.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Effect of chronic L-dopa or melatonin treatments after dopamine deafferentation in rats: dyskinesia, motor performance, and cytological analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin, mitochondria, and cellular bioenergetics

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Cell protective role of melatonin in the brain

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Calcium-dependent effects of melatonin inhibition of glutamatergic response in rat striatum

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin, mitochondrial homeostasis and mitochondrial-related diseases

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Tissue-plasminogen activator-induced ischemic brain injury is reversed by melatonin: role of iNOS and Akt.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Mitochondrial DNA and inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

In vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Apoptotic volume decrease and the incredible shrinking cell

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Parkinson's disease: pathophysiology

1 reference

https://api.crossref.org/works/10.1111%2FJPI.12212

21 January 2018

Identifiers

10.1111/JPI.12212

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/25626558

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48357495&oldid=2195809152"